Page 8 - Raches Ella News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Raches ella. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Raches Ella Today - Breaking & Trending Today

Bharat Biotech awaits emergency use approval from WHO for COVID-19 vaccine


Bharat Biotech awaits emergency use approval from WHO for COVID-19 vaccine
Firstpost
5 days ago
© Provided by Firstpost
Bharat Biotech awaits emergency use approval from WHO for COVID-19 vaccine
Bharat Biotech International Limited (BBIL) has applied to the World Health Organisation (WHO) to get an emergency use listing (EUL) for its COVID-19 vaccine. It hopes to get the nod by the third or fourth quarter of this year. BBIL has submitted 90 percent of required documents to WHO to get approval, and the remaining documents will be submitted by June, the Hyderabad-based pharma company told the Central government during a discussion. The meeting was attended by the company s managing director V Krishna Mohan and his colleagues, along with senior officers of the Ministry of Health, Department of Biotechnology and Ministry of External Affairs and Foreign Secretary Harsh Vardhan Shringla. Speaking to  ....

United Kingdom , India General , Andhra Pradesh , Astrazeneca Oxford , V Krishna Mohan , Raches Ella , Janssen Johnson , Vardhan Shringla , European Union , Bharat Biotech International Limited , Drug Administration , Ministry Of Health , Department Of Biotechnology , World Health Organisation , Ministry Of External Affairs , Bharat Biotech , Firstpost Bharat Biotech , Biotech International Limited , External Affairs , Foreign Secretary Harsh Vardhan , Hindustan Times , ஒன்றுபட்டது கிஂக்டம் , இந்தியா ஜநரல் , ஆந்திரா பிரதேஷ் , வ் கிருஷ்ணா மோகன் , ஜான்சன் ஜான்சன் ,

Regulatory approvals for COVAXIN is in process in more than 60 countries: Bharat Biotech


Regulatory approvals for COVAXIN is in process in more than 60 countries: Bharat Biotech
Hyderabad, May 25 (UNI) Regulatory approvals for indigenously developed Covid-19 vaccine ‘Covaxin’ are in process in more than 60 countries including USA, Brazil and Hungary, according to Hyderabad-based global vaccine maker Bharat Biotech here on Tuesday.
Emergency use authorisations (EUA) have been obtained from 13 countries with more to follow.
Bharat Biotech has submitted an application to the World Health Organisation (WHO ) for EUL (Emergency Use Listing) for indigenously developed Covid-19 vaccine ‘Covaxin ‘ and regulatory approvals are expected by Jul-Sept 2021.
Most countries recommend vaccinations against COVID-19.
Unvaccinated travelers can travel with negative RT-PCR tests prior to travel, in the absence of any other country specific travel restrictions. ....

United States , Andhra Pradesh , West Bengal , Tamil Nadu , Raches Ella , Bharat Biotechhyderabad , Suchitra Ella , Ladies Organisation , International Advocacy Of Bharath Biotech , World Health Organisation , Business Development , Bharat Biotech , Emergency Use Listing , Head Business Development , International Advocacy , Bharath Biotech , ஒன்றுபட்டது மாநிலங்களில் , ஆந்திரா பிரதேஷ் , மேற்கு பெங்கல் , தமிழ் நாடு , சூச்சித்ர எல்லா , பெண்கள் ஆர்கநைஸேஶந் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , வணிக வளர்ச்சி , பாரத் பயோடெக் , அவசரம் பயன்பாடு பட்டியல் ,

Paediatric trials of Covaxin may begin in June


Paediatric trials of Covaxin may begin in June
ANI |
Updated: May 24, 2021 03:06 IST
Hyderabad (Telangana) [India], May 24 (ANI): Bharat Biotech may begin paediatric trials of its Covid-19 vaccine Covaxin from June, said the company s Business Development and International Advocacy Head Dr Raches Ella on Sunday.
Holding a virtual conversation with members of FICCI Ladies Organisation (FLO) Hyderabad on All About Vaccines, he said that the company expected approval from the World Health Organisation (WHO) for Covaxin by the end of the third or fourth quarter.
I am happy that our hard work is paying off well as the vaccine is working well and saving lives. We have this good feeling when we go back home from work each day. We will be soon ramping up our manufacturing capacity to 700 million doses by the end of this year, informed Dr. Raches Ella as a response to a question from a participant. ....

Andhra Pradesh , Pragnya Chigurupati , Uma Chigurupati , Raches Ella , Union Government , International Advocacy Head Dr Raches Ella On , Ladies Organisation , World Health Organisation , Business Development , Bharat Biotech , International Advocacy Head Dr Raches Ella , About Vaccines , Bharath Biotech , Consultant Breast Oncology , Oncoplastic Surgeon , State Governments , Private Hospitals , Bharat Biotech , Dr Raches Ella , ஆந்திரா பிரதேஷ் , உமா சிகுருபடி , தொழிற்சங்கம் அரசு , பெண்கள் ஆர்கநைஸேஶந் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , வணிக வளர்ச்சி , பாரத் பயோடெக் ,